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Abstract Eukaryotic initiation factor (eIF) 4GI is e⁄ciently
cleaved during picornaviral replication. eIF4GI processing has
also recently been observed during HIV-1 replication. We have
compared the e⁄ciency of eIF4GI proteolysis in rabbit reticu-
locyte lysates during translation of mRNAs encoding the foot-
and-mouth disease virus leader proteinase (Lpro) or the HIV-1
proteinase (HIV-1pro). Lpro cleaved 50% eIF4GI within 12 min
whereas HIV-1pro required 4 h; the concentrations were 2 pg/Wl
(0.1 nM) for Lpro and 60 pg/Wl (2.66 nM) for HIV-1pro. HIV-
1pro processing of eIF4GI is therefore not quantitatively analo-
gous to that of Lpro, suggesting that the primary function of
eIF4GI cleavage in HIV-1 replication may not be protein syn-
thesis inhibition.
3 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
In eukaryotic cells, mRNA is recruited to the 40S ribosomal
subunit by the eIF4 (eukaryotic initiation factor 4) proteins
[1]. Members of the eIF4 group of initiation factors play a
central role in the initiation of protein synthesis in eukaryotes
[2]. These factors comprise the cap-binding protein eIF4E, the
RNA helicase eIF4A, the RNA binding protein eIF4B and
the adaptor protein eIF4G which occurs in two isoforms,
eIF4GI and eIF4GII [3]. In mammalian systems, eIF4E,
eIF4A and eIF4G can be isolated as a complex designated
eIF4F. eIF4F, together with eIF4B and eIF3, recognise the
cap structure at the 5P-end of the cellular mRNA, unwind
RNA secondary structure in an ATP-dependent manner and
enable binding of the 40S ribosomal subunit to the mRNA [4^
6].
The eIF4F complex is an important control point for the
overall rate of protein synthesis [7,8]. During the replication
of certain picornaviruses such as foot-and-mouth disease virus
(FMDV), human rhino- (HRV) and enteroviruses, translation
of capped cellular mRNA in the infected cell is shut down by
speci¢c cleavage of eIF4G isoforms [9^11]. Initiation of pro-
tein synthesis from viral mRNA is una¡ected as it initiates
internally and does not require a cap-structure [12].
Recently, experiments have shown that eIF4GI is cleaved
late in HIV-1-infected cells [13] and that puri¢ed HIV-1pro can
cleave eIF4GI in rabbit reticulocyte lysates (RRLs) [14]. The
proteolytic products of HIV-1pro are di¡erent to those of the
FMDV leader proteinase (Lpro). However, neither groups re-
ported on the e⁄ciency of the eIF4GI cleavage by HIV-1pro.
We show here that there is not only a qualitative di¡erence,
but also a signi¢cant quantitative di¡erence in the cleavage of
eIF4GI by FMDV Lpro and HIV-1pro.
2. Materials and methods
2.1. Plasmids
The plasmid pCITE FMDV LbproVP4VP2 containing the FMDV
nucleotides 892^1411 of the FMDV O1k cDNA [15] was described in
[16]. The plasmid encodes all 173 amino acids of the Lb form of Lpro,
all 85 amino acids of VP4 and 78 amino acids of VP2. The plasmid
pET11cHIV-1proD contains the cDNA for two HIV-1pro (BH10 strain)
monomers linked via a short hinge region of seven amino acids (Ala-
GlyAlaMetGlyGlyAla) and was derived from plasmid pT7-2PR [17].
This covalently linked HIV-1pro dimer was cloned into pCITE (No-
vagen) to generate pCITE HIV-1proD. pCITE vp6HIV-1proD was con-
structed as pCITE HIV-1proD except that it contains in addition the
sequence encoding the 20 amino acids from the C-terminus of the p6
transframe domain, the protein preceding the HIV-1pro in the genome.
2.2. In vitro transcription and translation
Plasmid pCITE FMDV Lbpro was linearised with SalI ; plasmids
pCITE HIV-1proD and pCITE vp6HIV-1proD were linearised with
BamHI. In vitro transcription with T7 RNA polymerase and in vitro
translation were as described in [16,18]. In vitro translation reactions
(typically 50 Wl) contained 70% RRL (Promega), 20 WCi of
[35S]methionine (1000 Ci/mmol, American Research Company) and
amino acids (except methionine) at 20 WM. After preincubation for
2 min at 30‡C, translation was started by addition of RNA to a
concentration of 15 ng/Wl unless stated otherwise. Aliquots (10 Wl)
were removed at the designated time points and the reaction was
stopped by immediate transfer to ice, the addition of unlabelled me-
thionine and cysteine to a ¢nal concentration of 2 mM and Laemmli
sample bu¡er.
2.3. Electrophoresis and immunoblotting
The polyacrylamide gel electrophoresis system described by Dasso
and Jackson [19] was used to separate translation products (gels con-
tained 15% acrylamide) and to monitor the state of eIF4GI (gels
contained 6% acrylamide). Translation products were detected by
£uorography (exposure to ¢lm was for 20 h); the state of eIF4GI
was determined by immunoblotting using the anti-(eIF4GI peptide 7)
antiserum as described in [16,18].
2.4. Quanti¢cation of protein synthesis
Quanti¢cation of protein synthesis using an Instant Imager (Can-
berra Packard) was as described previously, except that calculations
were adjusted for the use of [35S]methionine alone [16,18].
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3. Results
Lpro is the ¢rst protein encoded on the FMDV genome. As
protein synthesis initiates from one of two AUG codons, two
forms of Lpro, Labpro and Lbpro can be generated [20]. Both
forms have the same enzymatic activities [21]. Based on evi-
dence that the 28 amino acid shorter Lbpro form is the bio-
logically relevant one [22], we have consistently investigated
this form.
We have recently developed an RRL assay for the in vitro
proteolysis of eIF4GI by the FMDV Lbpro or the 2Apro of
rhino- and enteroviruses [18]. In this system, the picornaviral
proteinases are translated from a suitable mRNA, transcribed
in vitro and their synthesis detected by labelling with
[35S]methionine. As eIF4GI is abundant in the RRL, process-
ing of this molecule can be easily followed by immunoblot-
ting. Cleavage of eIF4GI by FMDV Lbpro is very e⁄cient; for
example, eIF4GI is cleaved to 50% after 8 min and to 90%
after 12 min at an Lbpro concentration of 20 pg/Wl (1 nM) at
the 12 min time-point [18].
The e⁄ciency of this reaction is underlined in Fig. 1 in
which the concentration of RNA (transcribed from pCITE
LbproVP4VP2) has been reduced by ¢ve fold compared to
that previously employed [18]. Self-processing of Lbpro be-
tween its own C-terminus and the N-terminus of VP4 is
very e⁄cient. No uncleaved precursor is visible. Lbpro itself
is just visible after 12 min (Fig. 1A); the VP4VP2 is less
intense, as it contains only two methionine codons compared
to the four in Lbpro. Despite the very low concentration of
Lbpro, cleavage of eIF4GI begins at 8 min; 50% processing is
observed at 12 min at an Lbpro concentration of about 2 pg/Wl
(0.1 nM) (Fig. 1B). eIF4GI itself migrates with a molecular
weight of 220 kDa as a series of bands [23]. The bands have
di¡erent N-termini which arise from the use of di¡erent AUG
codons during synthesis of eIF4GI [24]. Cleavage of eIF4GI
by Lbpro at its single recognition site between Gly674*Arg
(numbering according to [24]) generates a series of N-terminal
cleavage products which are detected by the N-terminal anti-
serum used here (cpN, Fig. 1B). The single C-terminal cleav-
age fragment is not detected by this antiserum. In summary,
the cleavage of eIF4GI by Lbpro is an extremely e⁄cient re-
action which can take place in RRLs at the low concentra-
tions of Lbpro found in FMDV-infected cells.
To compare the ability of eIF4GI in RRLs to serve as a
substrate for HIV-1pro, we synthesised RNA from plasmid
pCITE HIV-1proD, which contains two copies of part of the
HIV-1 cDNA encoding the proteinase gene product linked in
phase by a small oligonucleotide [17]. Translation of this
mRNA generates a tethered dimer which is immediately active
as dimerisation is not required. This strategy was followed as
it is believed that dimerisation is slow at pH 7 [25], the ap-
proximate pH of the RRL.
The expression of the HIV-1proD in RRLs was e⁄cient as
shown in Fig. 2A. However, cleavage products of eIF4GI
were not visible until 150 min after HIV-1proD synthesis had
Fig. 1. Cleavage of eIF4GI during in vitro translation of FMDV
Lbpro. RRLs were incubated with or without the mRNA of FMDV
Lbpro (0.2 ng/Wl) as described in Section 2; protein synthesis was
terminated at the times given by placing the samples on ice followed
by the addition of unlabelled methionine and cysteine to 2 mM and
Laemmli sample bu¡er. Aliquots (2 and 3 Wl, respectively) were ana-
lysed on 15% polyacrylamide gels followed by £uorography for the
synthesis of Lbpro (A) and on 6% polyacrylamide gels followed by
immunoblotting for the status of eIF4GI (B). The positions of the
uncleaved LbproVP4VP2 and the cleavage products Lbpro and
VP4VP2 are marked in (A); the concentration (in pg/Wl) of Lbpro
reached at each time point is indicated underneath the lane. In (B),
intact eIF4GI and the cleavage product cpN are marked. Protein
standards (in kDa) are indicated in both panels.
Fig. 2. Cleavage of eIF4GI during in vitro translation of the HIV-
1proD. mRNA was transcribed and used at a concentration of 15 ng/
Wl to programme HIV-1proD protein synthesis (A) as described in
Fig. 1. The positions of HIV-1proD are marked and the correspond-
ing concentrations (in pg/Wl) reached at each time point are indi-
cated underneath the lane. The cleavage of eIF4GI is analysed in
(B). o/N, over night (20 h).
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begun and cleavage was not complete until after 20 h of in-
cubation. The HIV-1proD cleavage products of eIF4GI are
di¡erent to those of Lbpro, as observed by Ohlmann et al.
[14]. Three products are visible for HIV-1proD, migrating at
150 kDa, 80 kDa and 70 kDa. As the 150 kDa species seems
to become less intense during the time-course of the incuba-
tion, it probably represents the precursor of the 80 kDa and
70 kDa fragments. These fragments are very similar to those
observed by Ohlmann [14]. It should be noted that some non-
speci¢c degradation of eIF4GI also took place during this
period of incubation (Fig. 2, no RNA lane). Further experi-
ments used an RNA which only encoded the HIV-1pro mono-
mer; however, no processing of eIF4GI was observed, sug-
gesting that the monomer indeed cannot dimerise in the RRLs
(data not shown).
This slower rate of cleavage seemed to indicate that eIF4GI
is a poor substrate for HIV-1pro. To ensure that this result was
not caused by the synthesis of an inactive HIV-1proD and to
show that the HIV-1proD was active at the pH of the RRLs,
we modi¢ed the DNA construction to include the 20 most
C-terminal amino acids of the p6 ‘transframe’ protein which
precedes the HIV-1pro in the gag reading frame of HIV-1
[26,27]. This enables the self-processing reaction to be moni-
tored in RRLs. Accordingly, RNA from this plasmid (pCITE
vp6HIVproD) was transcribed and used to drive protein syn-
thesis. As can be seen in Fig. 3A, two forms of HIV-1proD are
visible after 30 min, representing the vp6/HIV-1proD and the
mature dimer resulting from self-processing. After 2 h, all
material was in the cleaved form, indicating that the HIV-
1pro was fully active in self-processing in RRLs. Nevertheless,
analysis of the state of eIF4GI (Fig. 3B) shows that the ki-
netics are similar to those observed with the HIV-1proD pro-
tein which did not require self-processing (compare Fig. 2B
with Fig. 3B). No increase in cleavage rates was obtained
by decreasing the pH of the RRL to pH 6, although interpre-
tation was complicated by the apparent instability of eIF4GI
under these conditions (data not shown).
No processing of eIF4GII was observed during the time
courses used in these experiments (data not shown), con¢rm-
ing the observation of Ohlmann et al. [14] that eIF4GII is not
a substrate for HIV-1pro.
4. Discussion
The cleavage of the cellular protein eIF4GI by HIV-1pro has
been recently demonstrated. However, the role of eIF4GI
cleavage in HIV-1 replication was not elucidated; it has
been suggested that it may be involved in the ability of
HIV-1pro to inhibit host cell translation. As the HIV-1pro is
active at later times in HIV-1 infection, it is di⁄cult to imag-
ine a role for this cleavage in a¡ecting viral translation. To
understand cleavage of eIF4GI by HIV-1pro, we quantitated
the e⁄ciency of this cleavage using the FMDV Lbpro reaction
as a benchmark.
The results show clearly that HIV-1proD was much less e⁄-
cient in cleaving eIF4GI in RRLs than FMDV Lbpro. Even at
extremely low rates of Lbpro synthesis (2 pg/Wl, 0.1 nM), eIF4-
GI cleavage was still 50% complete after 12 min. In contrast,
even at much higher concentrations (65 pg/Wl), cleavage by
HIV-1proD was not initiated until about 150 min and was still
not complete after 20 h. This is also much slower than the
reaction involving HRV2 2Apro, which although requiring
higher concentrations (140 pg/Wl) than that found with Lpro,
can still process eIF4GI to 50% within 15 min [18]. That the
tethered dimer of HIV-1pro was active under these conditions
was demonstrated by including a piece of the p6 transframe
protein, which thus allowed the e⁄ciency of self-processing to
be monitored. Despite the low e⁄ciency of eIF4GI cleavage,
this system is a simple way of measuring HIV-1pro self-pro-
cessing and intermolecular activity on a polypeptide substrate
which is cleaved during infection.
Taken together, these results and those of Ohlmann [14]
indicate that HIV-1pro cleavage of eIF4GI is both quantita-
tively and qualitatively di¡erent from that of picornaviruses.
This sheds doubt on whether the cleavage of eIF4GI by HIV-
1pro is related to an e¡ect on protein synthesis during the
HIV-1 replicative cycle.
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